Harmonic Discovery Analysis: $8M Raised
What is Harmonic Discovery?
Harmonic Discovery utilizes machine learning for precision pharmacology, developing next-generation medicines by addressing disease complexity through multi-targeted drug discovery.
Employees
8
Founded
2021
Revenue
$0-5M
Product Features & Capabilities
- Engineering precision pharmacology, generative chemistry platform, multi-targeted drug discovery, integration of bioactivity data types, rational drug design.
How much Harmonic Discovery raised
Seed - $8 million
September 8, 2022Lead Investor: Innovation Endeavors, Fifty Years, Y Combinator, and other select investors.
Who are the founders of Harmonic Discovery
Business Model
Business model involves partnerships; revenue from licensing agreements and direct sales.
Market Focus
Harmonic Discovery primarily focuses on the biotechnology and pharmaceutical industry, specifically in the development of next-generation medicines using machine learning and precision pharmacology.
Investors
- Innovation Endeavors
- Fifty Years
- Y Combinator
- Boom Capital
- Caffeinated Capital
Competitors Overview
Harmonic Discovery operates in the field of precision pharmacology and machine learning for drug development. Its main competitors include:
- Deciphera Pharmaceuticals: This biopharmaceutical company focuses on developing new medicines for cancer treatment. They utilize a unique approach to ta
See something that needs updating? Suggest edits to this profile.